1 tablet contains ambroxol hydrochloride 30 mg
Release form:
Tablets for oral administration, 20 pieces per package
Pharmachologic effect:
Mucolytic drug with expectorant action.
It has secretomotor, secretolytic and expectorant effects. Stimulates serous cells of the bronchial mucosa, increases the content of mucous secretions and the release of surfactant (surfactant) in the alveoli and bronchi, normalizes the disturbed ratio of serous and mucous components of sputum.
By activating hydrolyzing enzymes and enhancing the release of lysosomes from Clara cells, ambroxol reduces the viscosity of sputum. Increases the motor activity of the ciliated epithelium, increases mucociliary transport, and facilitates the removal of mucus from the respiratory tract.
When ambroxol is taken orally, the effect, on average, occurs after 30 minutes and lasts 6-12 hours, depending on the size of the single dose.
Indications for use:
Acute and chronic diseases of the respiratory tract with the release of viscous sputum:
- acute and chronic bronchitis;
- pneumonia;
- COPD;
- bronchial asthma with difficulty in sputum discharge;
- bronchiectasis;
- treatment and prevention of respiratory distress syndrome (for syrup 3 mg/ml and solution for oral administration and inhalation).
Directions for use and dosage:
During treatment with Ambrohexal, it is necessary to drink plenty of fluids (juices, tea, water) to enhance the mucolytic effect of the drug.
The duration of treatment with Ambrohexal is determined by the doctor individually and depends on the severity of the disease. If it is necessary to use the drug for more than 4-5 days, consult a doctor.
The tablets should be taken orally after meals with sufficient liquid.
Adults and children over 12 years of age are prescribed 1 tablet. (30 mg) 3 times/day for the first 2-3 days. Then the dose of the drug should be reduced to 1 tablet. 2 times/day.
Children aged 6 to 12 years are prescribed 1/2 tablet. (15 mg) 2-3 times/day.
Contraindications:
- I trimester of pregnancy;
- lactation period (breastfeeding);
- children under 6 years of age (for tablets);
- lactase deficiency, lactose intolerance, glucose-galactose malabsorption (for tablets);
- hereditary fructose intolerance (for syrup);
- hypersensitivity to ambroxol and other components of the dosage forms of the drug.
Special instructions:
Ambroxol should not be taken simultaneously with antitussive drugs that can inhibit the cough reflex, for example, codeine, because this may make it difficult to remove liquefied mucus from the bronchi.
Ambroxol should be used with caution in patients with a weakened cough reflex or impaired mucociliary transport due to the possibility of sputum accumulation.
You should not take ambroxol immediately before bed.
In patients with bronchial asthma, ambroxol may increase cough.
Instructions for patients with diabetes: 1 tablet contains less than 0.01 XE; 1 measuring spoon (5 ml) of syrup 3 mg/ml contains 1.75 g of sorbitol (less than 0.15 XE); 1 scoop (5 ml) of 6 mg/ml syrup contains 2.525 g of sorbitol (0.21 XE).
Storage conditions:
The drug in tablet form should be stored out of the reach of children, protected from light at a temperature not exceeding 25°C.
Ambrohexal is a drug that has secretolytic, mucolytic and expectorant effects.
Composition, release form and analogues
The active ingredient of the drug is ambroxol. Auxiliary components are different and depend on the form of release.
Today the drug is sold in the following dosage forms:
- Ambrohexal tablets, 10 pieces in a blister, in one box 2, 5 or 10 blister packs;
- Ambrohexal capsules – 10 pieces in a blister, in cardboard packs of 1, 2 or 5 blister packs;
- Ambrohexal solution for inhalation and oral administration - 50 or 100 ml in bottles with a measuring cup included;
- Ambrohexal syrup - in bottles of 100 or 250 ml with a measuring spoon included.
Analogues of Ambrohexal are Ambrobene, Ambroxol, Ambrosol, Ambrolan, Ambrosan, Lazolvan, Lazolangin, Flavamed, Bronkhorus, Bronkhovern, Bronkhoxol, Mucobron, Suprima kof, Neo bronchol, Halixol.
Pharmacological action of Ambrohexal
The medicine has a secretolytic and expectorant effect.
The viscosity of sputum decreases due to depolymerization of mucopolysaccharides, which, in turn, is associated with the rupture of disulfide bonds in their molecules.
Ambroxol increases the transport of pathogenic agents, increases the activity of the ciliated epithelium, and normalizes the ratio of mucous and serous components of sputum fluid.
Due to the release of lysosomes and activation of hydrolyzing enzymes, Ambrohexal reduces the viscosity of sputum. This makes it easier to remove it from the respiratory tract.
The drug begins to act within half an hour after administration and is effective for 6-12 hours.
Indications for use of Ambrohexal
According to the instructions, Ambrohexal is prescribed to children and adults to reduce cough and facilitate expectoration of sputum in chronic and acute diseases of the lungs and bronchi, accompanied by disorders of bronchial secretion, as well as slowing down the separation of mucus and its further movement:
- Obstructive, chronic and acute bronchitis;
- Tracheitis;
- Bronchiectasis;
- Bronchial asthma.
To maintain the mucolytic effect, the drug is used for diseases such as rhinitis, sinusitis, laryngitis and pharyngitis.
In addition, it is advisable to use Ambrohexal as a prevention and treatment of complications after, as well as before, surgical intervention on the respiratory organs.
Finally, the drug is prescribed to pregnant women from 28 to 34 weeks with a threat of preterm labor or planned premature delivery. Ambrohexal stimulates intrauterine maturation of the lungs in the fetus and has a therapeutic and preventive effect in distress syndrome in premature infants.
Contraindications
The drug is contraindicated in case of hypersensitivity to ambroxol or auxiliary components. The medicine should not be used in the first trimester of pregnancy.
Ambrohexal tablets should not be given to children under 6 years of age, and daily capsules should not be given to children under 12 years of age.
The drug is prescribed with caution to patients with insufficient renal and liver function and for peptic ulcers of the duodenum and stomach.
How to use Ambrohexal
Ambrohexal tablets, according to the instructions, are taken orally after meals and washed down with a small amount of water. The recommended single dose for adults is 1 tablet (30 mg) three times a day. The maximum permissible dose is 2 tablets (60 mg) twice a day.
Daily capsules are also taken orally after meals. The capsule is swallowed whole and not chewed. Adults and children over 12 years of age are prescribed 75 mg (1 capsule) per day.
Ambrohexal syrup is taken orally during meals, washed down with water. Recommended doses of the drug:
- Adults and children over 12 years of age – two scoops three times a day. Maintenance therapy – 2 scoops twice a day;
- Children 6-12 years old – 5 ml of syrup 2-3 times a day;
- Children 2-5 years old - 2.5 ml of Ambrohexal syrup three times a day;
- Children under 2 years old – 2.5 ml of syrup twice a day.
Before using the drug in children under one year of age, you should consult a pediatrician.
The oral solution is added to juice, tea or water and taken after meals. Children under 2 years of age are prescribed 1 ml of the drug twice a day. Children 2-6 years old - 1 ml of solution three times a day, 6-12 years old - 2 ml Ambrohexal three times a day, over 12 years old and adults - 4 ml three times a day.
Ambrohexal solution for inhalation is mixed with physiological solution in a 1:1 ratio. It is intended for use in special inhalers - nebulizers. Adults and children over 6 years old are prescribed 2-3 ml of solution three times a day, children 2-6 years old - 2 ml twice a day, children under 2 years old - 1 ml 1 or 2 times a day.
Side effects
The instructions for Ambrohexal say that it can cause the following undesirable reactions:
- Nausea, vomiting;
- Gastralgia;
- Dry mouth;
- Diarrhea, constipation;
- Allergic reactions in the form of urticaria, skin rash, bronchospasm attack, angioedema, and in very rare cases, anaphylactic shock;
- Chills and fever.
It is extremely rare to experience headache, weakness, increased salivation, dryness in the upper respiratory tract, dysuria (impaired urination).
Ambrohexal drug interactions
Simultaneous use with antibiotics (erythromycin, amoxicillin) leads to an increase in their concentration in sputum and bronchopulmonary secretions.
When taken in combination with antitussives containing codeine, sputum stagnation is possible due to inhibition of the cough center.
Ambrohexal can be used with medications used for bronchial syndrome (bronchospasmolytics, glucocorticosteroids, cardiac glycosides, diuretics).
Storage conditions
Ambrohexal in any form should be stored at a temperature not exceeding 25 ° C in a place protected from light. Do not use after expiration date.
Ambrohexal solution- expectorant, mucolytic agent.
Has secretomotor, secretolytic and expectorant effects; stimulates the serous cells of the glands of the bronchial mucosa, increases the content of mucous secretion and the release of surfactant in the alveoli and bronchi; normalizes the disturbed ratio of serous and mucous components of sputum. By activating hydrolyzing enzymes and enhancing the release of lysosomes from Clark cells, it reduces the viscosity of sputum. Increases the motor activity of the cilia of the ciliated epithelium, increases the mucociliary transport of sputum.
After oral administration, the effect occurs within 30 minutes. and continues for 6-12 hours.
Pharmacokinetics
Absorption is high, time to reach maximum concentration is 0.5-3 hours, binding to blood plasma proteins is 80-90%, penetrates the blood-brain barrier, placental barrier, and is excreted in breast milk.
The drug is metabolized in the liver to inactive metabolites (dibromanthranilic acid and glucuronic conjugates). The half-life (T1/2) is from 7 to 12 hours. Excreted by the kidneys: 90% in the form of metabolites, 10% unchanged.
Indications for use:
SolutionAmbrohexal used for the treatment of acute and chronic diseases of the respiratory tract with the release of viscous sputum: acute and chronic bronchitis, pneumonia, chronic obstructive pulmonary disease, bronchial asthma with difficulty in sputum discharge, bronchiectasis.
Mode of application:
Oral administration (1 ml = 20 drops) of solution Ambrohexal.
Children over 12 years of age and adults: the first 2-3 days - 3 times 4 ml (30 mg of ambroxol g/x) per day, then - 2 times 4 ml.
Children aged 5-12 years: 2-3 times a day, 2 ml (15 mg ambroxol g/x).
Children aged 2 to 5 years: 3 times a day, 1 ml (7.5 mg ambroxol g/x)
Children under 2 years old: 1 ml 2 times a day (7.5 mg ambroxol g/x)
Ambrohexal should be taken after meals diluted with tea, fruit juices, milk or water.
During treatment, it is necessary to drink plenty of fluids (juices, tea, water) to enhance the mucolytic effect of the drug.
Application for inhalation of Ambrohexal solution.
For adults and children over 5 years of age, it is recommended to inhale 2-3 ml (40-60 drops, which corresponds to 15-22.5 mg of ambroxol g/x) 1-2 times a day;
Children under 5 years of age are recommended to inhale 2 ml (40 drops, which corresponds to 15 mg of ambroxol g/x) 1-2 times a day.
For inhalation, you must use a suitable device in compliance with the instructions for use.
The duration of therapy depends on the severity of the disease and is determined by the attending physician. Without a doctor's recommendation, you should not take Ambrohexal for more than 4-5 days.
Side effects:
From the digestive system: nausea, vomiting, gastralgia, diarrhea, constipation, dry mouth.
Allergic reactions: skin rash, urticaria, angioedema, in rare cases - anaphylactic shock.
Rarely: weakness, headache, rhinorrhea.
Contraindications:
Contraindications to the use of the solution Ambrohexal are: hypersensitivity to the components of the drug, pregnancy (first trimester).
With caution - The drug should be used with caution in patients with gastric and duodenal ulcers, since exacerbation of peptic ulcer disease may occur, as well as in patients with renal and liver failure.
Pregnancy:
A drug Ambrohexal solution It is not recommended to use during the first trimester of pregnancy. If it is necessary to use ambroxol in the II-III trimesters of pregnancy, the potential benefit for the mother should be assessed with the possible risk to the fetus.
During breastfeeding, use the drug with caution, as it is excreted into breast milk.
Interaction with other drugs:
When using Ambrohexal with antitussive drugs, it may be difficult to clear sputum as a result of suppression of the cough reflex. When used simultaneously with amoxicillin, cefuroxime, erythromycin, and doxycycline, ambroxol increases their concentration in bronchial secretions.
Overdose:
Overdose symptoms Ambrohexal not described in humans.
Possible: nausea, vomiting, gastralgia. Treatment: artificial vomiting, gastric lavage in the first 1-2 hours after taking the drug; intake of fat-containing foods, symptomatic therapy.
Storage conditions:
Store the drug in a place protected from light at a temperature not exceeding 25°C!
Keep the medicine out of the reach of children!
Release form:
Ambrohexal - oral solution.
50 ml or 100 ml in a dark glass dropper bottle.
A dropper bottle with a measuring cup in a cardboard box with instructions for use.
Compound:
1 ml solution (about 20 drops) Ambrohexal contains the active substance - ambroxol hydrochloride 7.5 mg.
Excipients - methyl parahydroxybenzoate, propyl parahydroxybenzoate, sodium metabisulfite, citric acid anhydride, sodium hydroxide, purified water.
Additionally:
Ambrohexal should be used with caution in patients with a weakened cough reflex or impaired mucociliary transport due to the possibility of sputum accumulation.
Patients taking ambroxol should not be recommended to perform breathing exercises; in seriously ill patients, aspiration of liquefied sputum should be performed.
In patients with bronchial asthma, ambroxol may increase cough.
You should not take ambroxol immediately before bed.
Ambroxol should not be taken simultaneously with antitussive drugs that can inhibit the cough reflex, for example, codeine, because this may make it difficult to remove liquefied mucus from the bronchial tree.
Coughing is an unconditioned reflex that occurs when the mucous membrane of the respiratory tract is irritated. It can appear when ingested by a foreign body, allergens, as well as viruses, bacteria and fungi. Often a cold is complicated by a cough. In case of infectious diseases, cough clears the bronchi, trachea, larynx and pharynx of mucus.
Ambrohexal for inhalation promotes rapid mucus discharge and recovery. The cough develops in two stages: first dry, then with sputum discharge. Like any other mucolytic agent, Ambrohexal is intended to treat only wet cough caused by infection.
On this page you will find all the information about Ambrohexal solution for inhalation: complete instructions for use for this drug, average prices in pharmacies, complete and incomplete analogues of the drug, as well as reviews of people who have already used Ambrohexal. Would you like to leave your opinion? Please write in the comments.
Clinical and pharmacological group
Mucolytic and expectorant drug.
Conditions for dispensing from pharmacies
The drug is approved for use as a means over-the-counter.
Prices
How much does Ambrohexal solution cost? The average price in pharmacies is 190 rubles.
Release form and composition
Solution for oral administration and inhalation 7.5 mg 50 ml or 100 ml in a dark glass bottle equipped with a plastic divider with a plastic screw cap and a first opening ring. A bottle with a polypropylene measuring cup in a cardboard box along with instructions for use.
- 1 ml of solution (about 20 drops) contains: active substance – ambroxol hydrochloride 7.5 mg;
- excipients – methyl parahydroxybenzoate, propyl parahydroxybenzoate, sodium metabisulfite, citric acid, sodium hydroxide, water.
Pharmacological effect
The drug exhibits secretomotor, secretolytic and expectorant properties, stimulates glandular serous cells of the bronchial mucosa, increases the amount of mucosal secretion and the release of surfactant in the bronchi and alveoli, restores the normal ratio of mucous and serous components of sputum. In addition, it reduces the viscosity of sputum by activating hydrolyzing enzymes and increasing the release of lysosomes from Clara cells. Increases the movements of the cilia of the ciliated epithelium, accelerates mucociliary transport than promotes the removal of phlegm.
Ambroxol begins to act thirty minutes after ingestion and lasts up to six to twelve hours (in accordance with the single dose taken). After taking the drug absorbed quickly and almost completely. The maximum concentration of ambrohexal is determined after one to three hours. It is converted in the liver, after which metabolites (glucuronides, dibromanthranilic acid) are excreted through the kidneys.
Indications for use
Ambrohexal is usually used to treat infectious diseases that are accompanied by prolonged cough and poor sputum discharge. Thanks to the steam with the active substance, inhalation allows direct act on the affected area. In addition, high temperatures prevent viruses and bacteria from multiplying. Thus, the action occurs on both sides. Sputum comes out faster, and pathogenic microflora stops spreading and dies.
The effect of the drug can be experienced in the treatment of such diseases:
- Bronchiectasis disease,
- and in the chronic stage,
- Cystic fibrosis,
Inhalations will help reduce treatment time, if the procedures are carried out at the first signs of the disease. Ambrohexal is not used for allergic coughs, since there are no inflammatory reactions in the bronchi; instead, some allergen acts, which causes irritation of the mucous membrane.
Bronchial asthma is accompanied by prolonged bouts of coughing; it can appear for various reasons; it is caused by:
Ambrohexal is used for any asthma, except allergic(without infection). Inhalations are carried out with several drugs. First, bronchodilators are used, then mucolytics, such as Ambrohexal, and finally anti-inflammatory drugs.
Contraindications
Hypersensitivity to the components of the drug, pregnancy (first trimester).
With caution: The drug should be used with caution in patients with gastric and duodenal ulcers, since exacerbation of peptic ulcer disease may occur, as well as in patients with renal and liver failure.
Use during pregnancy and lactation
The drug is contraindicated for use in the first trimester of pregnancy.
The use of the drug in the second and third trimesters of pregnancy is possible only if the expected benefit to the mother outweighs the potential risk to the fetus.
Ambroxol penetrates the placental barrier. IN experimental studies It has been shown in animals that the drug has no effect on embryofetal development, childbirth and postnatal development.
Ambroxol is excreted in small quantities into breast milk, therefore, when using the drug Ambrohexal, it is necessary to decide on stopping breastfeeding.
Instructions for use for Ambrohexal solution
The instructions for use indicate that adults and children over 5 years of age are recommended to inhale 1-2 times a day, 2-3 ml (40-60 drops, which corresponds to 15-45 mg of ambroxol). Children under 5 years of age are recommended to inhale 2 ml (40 drops, which corresponds to 15-30 mg of ambroxol) 1-2 times a day.
The inhalation solution can be used using any modern inhalation equipment (except steam inhalers). The drug is mixed with saline; to achieve an optimal level of air humidification in the respirator, the drug can be diluted in a 1:1 ratio. Since during inhalation therapy, a deep breath can provoke coughing impulses, inhalations should be carried out in normal breathing mode.
Side effects
This drug, like many other products of the pharmaceutical industry, has a number of side effects that may occur in a certain category of patients. During testing of the inhalation solution, some patients exhibited the following side properties, namely:
- Allergy. Manifestations such as hives on the skin and a small red rash on the chest, neck and back were recorded. There were practically no extensive allergic reactions in the form of anaphylactic shock in medical practice.
- Disorders of the gastrointestinal tract. Such phenomena as nausea, diarrhea, vomiting, and lack of appetite were observed.
- Nervous disorders. Rarely, but still there were cases when the sensitivity of taste buds was impaired in patients. Some people did not feel the oral cavity and pharynx after inhalation. A few hours after the procedure was completed, sensitivity returned again.
Each organism is individual, therefore, at all stages of inhalation and treatment of inflammatory diseases in the lungs, you should pay attention to how the body behaves after the active components of Ambrohexal enter the blood.
Overdose
As a rule, with an overdose of Ambrohexal, severe symptoms of poisoning are not observed. Minor nervous system disturbances and diarrhea have been reported. In rare cases of overdose, the patient experienced increased salivation (hypersalivation), vomiting, and decreased blood pressure. At the first signs of overdose, you should consult a doctor.
If you miss an inhalation medication, do not take a double dose of the medication to make up for the omission. You should continue to use the drug according to the instructions at the usual dosage. Sudden cessation of use of Ambrohexal may cause a deterioration in the patient's condition.
special instructions
It should be used with extreme caution in patients with a weakened cough reflex or impaired mucociliary transport, since in this situation inhalation can cause sputum accumulation. Also, during the treatment period it is not recommended to perform breathing exercises. In patients suffering from bronchial asthma, cough may increase while using the drug.
Patients with impaired fructose tolerance should consult their doctor before starting inhalations.
There is no data on the effect on the ability to drive vehicles and control various mechanisms.
Drug interactions
When using Ambrohexal solution for inhalation and antitussive drugs, accumulation of sputum in the bronchi may occur, so this combination therapy should be used with caution.
The combined use of Ambrohexal and antibacterial agents (for example, amoxicillin) leads to improved absorption of antibiotics in the lung tissue and promotes a speedy recovery.
Ambrohexal belongs to the group of benzylamines and is a synthetic mucolytic agent. The drug has a secretolytic and stimulating effect on the cells of the bronchial mucosa.
As a result, the secretion of mucus increases. The drug Ambroxol has a weak antitussive effect and has anti-inflammatory and antioxidant properties.
In this article we will look at why doctors prescribe Ambrohexal, including instructions for use, analogues and prices for this drug in pharmacies. Real REVIEWS of people who have already used Ambrohexal can be read in the comments.
Composition and release form
Ambrohexal solution is produced for inhalation, as well as for intravenous administration. You can also find tablets, rectal suppositories and Ambrohexal syrup in pharmacies.
- The active ingredient of the drug is ambroxol. Auxiliary components are different and depend on the form of release.
Clinical and pharmacological group: mucolytic and expectorant drug.
Indications for use
According to the instructions, Ambrohexal is used for children and adults to facilitate expectoration of sputum and reduce cough in various acute and chronic diseases of the bronchi and lungs, with disorders of bronchial secretion and weakening of the separation and movement of mucus:
- acute and chronic bronchitis;
- bronchiectasis;
- bronchial asthma;
- bronchiolitis;
- cystic fibrosis;
- rhinitis, sinusitis.
Ambrohexal is also used to prevent complications and treat complications before and after surgical interventions on the respiratory system. It is also used in cases where there is a threat of premature birth or when premature delivery is indicated from 28 to 34 weeks of pregnancy, to stimulate intrauterine maturation of the lungs in the fetus, and for the prevention and treatment of distress syndrome in premature infants.
pharmachologic effect
The active substance of Ambrohexal - ambroxol hydrochloride - is a mucolytic and expectorant of the benzylamine group.
By stimulating the activity of the serous cells of the glands of the bronchial mucosa and increasing the content of the mucous secretion, it normalizes the pathologically disturbed balance of the serous and mucous components of the bronchial secretion. At the same time, ambroxol hydrochloride increases the formation of lysosomes from Clark cells, this leads to a decrease in the viscosity of sputum, stimulates the activity of the villi of the respiratory tract and facilitates the separation of sputum from the walls of the bronchi.
Instructions for use
During treatment with Ambrohexal, it is necessary to drink plenty of fluids (juices, tea, water) to enhance the mucolytic effect of the drug.
The tablets should be taken orally after meals with sufficient liquid:
- Adults and children over 12 years of age are prescribed 1 tablet. (30 mg) 3 times/day for the first 2-3 days. Then the dose of the drug should be reduced to 1 tablet. 2 times/day.
- Children aged 6 to 12 years are prescribed 1/2 tablet. (15 mg) 2-3 times/day.
Ambrohexal solution for oral administration and inhalation 7.5 mg/ml instructions
Ingestion:
- Adults and children over 12 years of age are prescribed 4 ml (80 drops) 3 times/day (90 mg/day) in the first 2-3 days, then 4 ml (80 drops) 2 times/day (60 mg/day ).
- Children aged 5 to 12 years are prescribed 2 ml (40 drops) 2-3 times a day (30-45 mg/day).
- Children aged 2 to 5 years are prescribed 1 ml (20 drops) 3 times a day (22.5 mg/day).
- Children under 2 years of age are prescribed 1 ml (20 drops) 2 times a day (15 mg/day). The drug is prescribed only under the supervision of a physician.
Application in the form of inhalations:
- Adults and children over 5 years of age are recommended to inhale 1-2 times a day, 2-3 ml (40-60 drops, which corresponds to 15-45 mg of ambroxol).
- Children under 5 years of age are recommended to inhale 2 ml (40 drops, which corresponds to 15-30 mg of ambroxol) 1-2 times a day.
The inhalation solution can be used using any modern inhalation equipment (except steam inhalers). The drug is mixed with saline; to achieve an optimal level of air humidification in the respirator, the drug can be diluted in a 1:1 ratio. Since during inhalation therapy, a deep breath can provoke coughing impulses, inhalations should be carried out in normal breathing mode. Before inhalation, it is usually recommended to warm the inhalation solution to body temperature. For patients with bronchial asthma, inhalation may be recommended after taking bronchodilators.
The duration of treatment is determined by the doctor individually depending on the indications and severity of the disease. A doctor's supervision is necessary when taking the product for longer than 4-5 days.
Contraindications
Contraindications to the use of Ambrohexal are hypersensitivity to the active ingredient (ambroxol hydrochloride) or excipients included in the dosage form of the drug and pregnancy, especially in the early stages.
Side effects
The use of Ambrohexal causes some side effects: nausea, weakness, constipation, vomiting, headache, skin rashes, urticaria, itching, anaphylactic shock, rhinorrhea, dry mouth, diarrhea.
In case of an overdose of the drug, dyspepsia, vomiting, nausea, and diarrhea may occur. In this case, it is recommended to stop taking the drug, rinse the stomach, induce vomiting, and eat more foods containing fats.
Ambrohexal's analogs
Structural analogues of the active substance:
- Ambrobene;
- Ambroxol;
- Ambrolan;
- Ambrosan;
- Ambrosol;
- Bronchoxol;
- Bronchorus;
- Deflegmin;
- Bronchovern drops;
- Lazolangin;
- Lazolvan;
- Medox;
- Mucobron;
- Neo Bronchol;
- Remebrox;
- Suprima coffee;
- Fervex for cough;
- Flavamed;
- Halixol.
Attention: the use of analogues must be agreed with the attending physician.
